Sonova Holding (OTCMKTS:SONVY) Given Average Rating of “Hold” by Analysts

Sonova Holding (OTCMKTS:SONVY) has been assigned a consensus recommendation of “Hold” from the seven analysts that are covering the firm, Marketbeat reports. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating, two have given a buy rating and one has assigned a strong buy rating to the company.

A number of equities research analysts have recently issued reports on SONVY shares. Citigroup reiterated a “sell” rating on shares of Sonova in a research note on Friday, July 24th. Morgan Stanley upgraded shares of Sonova from an “underweight” rating to an “equal weight” rating in a report on Tuesday, June 23rd. Finally, UBS Group raised shares of Sonova from a “hold” rating to a “buy” rating in a research report on Wednesday, July 22nd.

Sonova Stock Up 0.7%

OTCMKTS:SONVY opened at $60.83 on Monday. Sonova has a 1 year low of $42.26 and a 1 year high of $61.09. The company has a debt-to-equity ratio of 0.51, a current ratio of 1.75 and a quick ratio of 1.43. The stock has a 50-day moving average price of $52.82 and a two-hundred day moving average price of $50.14.

Sonova Company Profile

Sonova AG (OTCMKTS:SONVY) is a Switzerland-based provider of hearing care solutions, headquartered in Stäfa. The company designs, develops, manufactures and distributes a range of audiological products and related services aimed at improving hearing and communication for people with hearing loss. Its portfolio spans behind-the-ear and in-the-ear hearing instruments, wireless accessories and software solutions that enable connectivity with consumer devices and audiological fittings.

Sonova markets its products under several well-known brands, including Phonak and Unitron for hearing aids, and it is also associated with Advanced Bionics for cochlear implant systems.